Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Return on Equity (2011 - 2026)

Mimedx recorded quarterly Return on Equity of 0.0% in Q1 2026, down 4302.2% quarter-over-quarter from 0.0% in Q2 2025, and little changed year-over-year from 0.0% in Q1 2025.

Mimedx's Return on Equity history runs 16 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • In Q1 2026, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2024 annual figure was 0.0%, changed 0.0% from the prior year.
  • Return on Equity came in at 0.0% for Q1 2026 at Mimedx, down from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.04% in Q1 2022 to a low of 0.0% in Q4 2023.
  • A 5-year average of 0.01% and a median of 0.0% in 2024 frame the typical range for Return on Equity.
  • Across the five-year window, Return on Equity slipped 9 bps in 2022 and changed 0 bps in 2024, its largest moves.
  • Mimedx's Return on Equity stood at 0.01% in 2022, then tumbled by 112 bps to 0.0% in 2023, then soared by 102 bps to 0.0% in 2024, then tumbled by 54 bps to 0.0% in 2025, then tumbled by 4302 bps to 0.0% in 2026.
  • According to Business Quant data, Return on Equity over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -0.04%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -0.01%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.00%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.00%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.01%
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn 0.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.01%
Mar 31, 2023 0.01%
Dec 31, 2022 0.01%
Sep 30, 2022 0.02%
Jun 30, 2022 0.02%
Mar 31, 2022 0.04%
Dec 31, 2021 0.04%
Sep 30, 2021 0.04%
Jun 30, 2021 0.06%
Mar 31, 2021 0.13%
Dec 31, 2020 -0.08%
Sep 30, 2020 -0.02%
Jun 30, 2020 0.00%
Mar 31, 2020 -0.01%
Dec 31, 2019 -0.01%
Sep 30, 2019 -0.02%
Jun 30, 2019 -0.02%
Mar 31, 2019 -0.01%
Dec 31, 2018 0.00%
Sep 30, 2018 0.00%
Jun 30, 2018 0.00%
Mar 31, 2018 0.00%
Dec 31, 2017 0.00%
Sep 30, 2017 0.00%
Jun 30, 2017 0.00%
Mar 31, 2017 0.00%
Dec 31, 2016 0.00%
Sep 30, 2016 0.00%
Jun 30, 2016 0.00%
Mar 31, 2016 0.00%
Dec 31, 2015 0.00%
Sep 30, 2015 0.00%
Jun 30, 2015 0.00%
Mar 31, 2015 0.00%
Dec 31, 2014 0.00%
Sep 30, 2014 0.00%
Jun 30, 2014 0.00%
Mar 31, 2014 0.00%
Dec 31, 2013 0.00%
Sep 30, 2013 0.00%
Jun 30, 2013 0.00%
Mar 31, 2013 0.00%
Dec 31, 2012 0.00%
Sep 30, 2012 0.00%
Jun 30, 2012 0.00%
Mar 31, 2012 -0.01%
Dec 31, 2011 -0.01%
Sep 30, 2011 -0.01%